Nautilus Biotechnology, Inc. — Investor Relations & Filings
Nautilus Biotechnology, Inc. is a life sciences company developing a platform to revolutionize proteome analysis. The company's Proteome Analysis Platform is designed to quantify proteins at the single-molecule level, leveraging a proprietary method called Iterative Mapping. This technology aims to provide high-resolution views of billions of individual protein molecules and their modifications (proteoforms). The platform is being developed with two key modalities: broadscale proteomic analysis for comprehensive proteome exploration and targeted proteoform analysis for in-depth examination of protein variants. The intended applications include accelerating drug target identification, discovering more effective biomarkers, and enabling foundational biological research by making advanced proteomics more accessible to the scientific community.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2022-08-02 | English | |
| 8-K | 2022-08-01 | English | |
| FORM 3 | 2022-07-01 | English | |
| FORM 4 | 2022-06-28 | English | |
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2022-06-17 | English | |
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2022-06-17 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 13249450 | 10-Q | 2022-08-02 | English | ||
| 13249452 | 8-K | 2022-08-01 | English | ||
| 13249453 | FORM 3 | 2022-07-01 | English | ||
| 13249454 | FORM 4 | 2022-06-28 | English | ||
| 13249455 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2022-06-17 | English | ||
| 13249456 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2022-06-17 | English | ||
| 13249459 | FORM 4 | 2022-06-16 | English | ||
| 13249457 | FORM 4 | 2022-06-16 | English | ||
| 13249458 | FORM 4 | 2022-06-16 | English | ||
| 13249460 | FORM 4 | 2022-06-16 | English | ||
| 13249461 | FORM 4 | 2022-06-16 | English | ||
| 13249462 | FORM 4 | 2022-06-16 | English | ||
| 13249463 | 424B3 | 2022-06-16 | English | ||
| 13249464 | 8-K | 2022-06-16 | English | ||
| 13249465 | FORM 4 | 2022-05-13 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Nautilus Biotechnology, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34183/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34183 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34183 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34183 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34183}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Nautilus Biotechnology, Inc. (id: 34183)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.